lynestrenol
Trade name: Exluton
Small moleculeexperimental
Lynestrenol, sold under the brand names Exluton and Ministat among others, is a progestin medication which is used in birth control pills and in the treatment of gynecological disorders. The medication is available both alone and in combination with an estrogen. It is taken by mouth. — Wikipedia
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Jun 1, 2000 (NCT00647933)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Progesterone receptorAGONIST
PGR agonist
Chemistry & pharmacology
Loading structure…
SMILES
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C- Mol. weight
- 284.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLynestrenol ↗
- ChEMBLCHEMBL2107431 ↗
Also known as
- ethynylestrenol
- linestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynestrenol
- lynoestrenol
- lynoestrenol
- orgametril
- orgametrol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02715232 | Phase 4 | Feb 6, 2017 | University of Vienna |
| NCT01065220 | Phase 4 | Feb 1, 2010 | University of Vienna |
| NCT00647933 | Phase 1 | Jun 1, 2000 | Merck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Vienna | Academic/Hospital | 2 | 2 | 1 | 2010 |
| Merck | For profit | 1 | 1 | 1 | 2000 |
2 organizations
Page 1 / 1